Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Vera Balz

Showing results (1-10 of 40) with videos related to

Pageof 4
Sort By:
Advances in Oto-Rhino-Laryngology|December 21, 2004
p53, p63 and p73 expression in squamous cell carcinomas of the head and neck and their response to cisplatin exposureChristian Gwosdz, Vera Balz, Kathrin Scheckenbach, et al.
HLA|August 30, 2018
A novel HLA-B variant, HLA-B*14:02:16, discovered by amplicon-based next-generation sequencingVera Balz, Johannes Fischer, Stefan Krause, et al.
HLA|August 30, 2018
A novel HLA-A null allele, HLA-A*30:130N, discovered by amplicon-based next-generation sequencingVera Balz, Johannes Fischer, Stefan Krause, et al.
Cancer Genetics and Cytogenetics|December 31, 2002
Analysis of BRCA1, TP53, and TSG101 germline mutations in German breast and/or ovarian cancer familiesVera Balz, Hans Bernd Prisack, Henning Bier, et al.
BMC Medical Genetics|December 24, 2008
An intronic alteration of the fibroblast growth factor 10 gene causing ALSG-(aplasia of lacrimal and salivary glands) syndromeKathrin Scheckenbach, Vera Balz, Martin Wagenmann, et al.
Cancer Research|March 22, 2003
Is the p53 inactivation frequency in squamous cell carcinomas of the head and neck underestimated? Analysis of p53 exons 2-11 and human papillomavirus 16/18 E6 transcripts in 123 unselected tumor specimensVera Balz, Kathrin Scheckenbach, Karl Götte, et al.
Genes, Chromosomes & Cancer|October 21, 2004
Homozygous deletions of CDKN2A caused by alternative mechanisms in various human cancer cell linesSascha Raschke, Vera Balz, Thomas Efferth, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|November 10, 2004
p53 codon 72 polymorphic variants, loss of allele-specific transcription, and human papilloma virus 16 and/or 18 E6 messenger RNA expression in squamous cell carcinomas of the head and neckKathrin Scheckenbach, Oliver Lieven, Karl Götte, et al.
Melanoma Research|June 22, 2011
Analysis of the functional integrity of the p53 tumor-suppressor gene in malignant melanomaAndreas Knopf, Christian Plettenberg, Anja Pickhard, et al.
International Journal of Cancer|August 12, 2005
Comprehensive analysis of the p53 status in mucosal and cutaneous melanomasChristian Gwosdz, Kathrin Scheckenbach, Oliver Lieven, et al.
Pageof 4

Showing results (1-10 of 40) with videos related to

Sort By:
Pageof 4
Advances in Oto-Rhino-Laryngology|December 21, 2004
p53, p63 and p73 expression in squamous cell carcinomas of the head and neck and their response to cisplatin exposureChristian Gwosdz, Vera Balz, Kathrin Scheckenbach, et al.
HLA|August 30, 2018
A novel HLA-B variant, HLA-B*14:02:16, discovered by amplicon-based next-generation sequencingVera Balz, Johannes Fischer, Stefan Krause, et al.
HLA|August 30, 2018
A novel HLA-A null allele, HLA-A*30:130N, discovered by amplicon-based next-generation sequencingVera Balz, Johannes Fischer, Stefan Krause, et al.
Cancer Genetics and Cytogenetics|December 31, 2002
Analysis of BRCA1, TP53, and TSG101 germline mutations in German breast and/or ovarian cancer familiesVera Balz, Hans Bernd Prisack, Henning Bier, et al.
BMC Medical Genetics|December 24, 2008
An intronic alteration of the fibroblast growth factor 10 gene causing ALSG-(aplasia of lacrimal and salivary glands) syndromeKathrin Scheckenbach, Vera Balz, Martin Wagenmann, et al.
Cancer Research|March 22, 2003
Is the p53 inactivation frequency in squamous cell carcinomas of the head and neck underestimated? Analysis of p53 exons 2-11 and human papillomavirus 16/18 E6 transcripts in 123 unselected tumor specimensVera Balz, Kathrin Scheckenbach, Karl Götte, et al.
Genes, Chromosomes & Cancer|October 21, 2004
Homozygous deletions of CDKN2A caused by alternative mechanisms in various human cancer cell linesSascha Raschke, Vera Balz, Thomas Efferth, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|November 10, 2004
p53 codon 72 polymorphic variants, loss of allele-specific transcription, and human papilloma virus 16 and/or 18 E6 messenger RNA expression in squamous cell carcinomas of the head and neckKathrin Scheckenbach, Oliver Lieven, Karl Götte, et al.
Melanoma Research|June 22, 2011
Analysis of the functional integrity of the p53 tumor-suppressor gene in malignant melanomaAndreas Knopf, Christian Plettenberg, Anja Pickhard, et al.
International Journal of Cancer|August 12, 2005
Comprehensive analysis of the p53 status in mucosal and cutaneous melanomasChristian Gwosdz, Kathrin Scheckenbach, Oliver Lieven, et al.
Pageof 4